Korber pharma PAS-x MAS suite
Active Definitive Contract Awarded Last action
- Contract number
- 75N90024C00029
- Awardee
-
Korber Pharma Software, Inc. UEI ZA6HHQA9A2Q9
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $955,560
Award facts
- Opportunity
-
- Körber Pharma Software, Inc PAS-X MES Manufacturing Execution System Pre-Solicitation · Posted May 15, 2024
- Contract value 100% obligated
- $955,560.40 Current and potential, with all options
- Completion date 41% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $71,068 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $884,492 |
About this award
The National Institutes of Health Clinical Center awarded a definitive, firm fixed-price contract to Korber Pharma Software, Inc. (UEI: ZA6HHQA9A2Q9) on August 1, 2024, for the implementation, installation, and configuration of a Manufacturing Execution System (MES) platform. The PAS-X MAS Suite system, valued at $955,560.40 with completion targeted for December 31, 2029, will support the Center of Cellular Engineering's manufacturing operations in Bethesda, Maryland. This non-competed, sole-source award was conducted under simplified acquisition procedures and reflects the vendor's specialized expertise in deploying GMP-ready MES solutions tailored to cell and gene therapy manufacturing environments comparable to the NIH Clinical Center's operational requirements.
The PAS-X system will enhance the safety and effectiveness of cellular therapies by providing a manufacturing execution platform capable of efficient deployment within 12 months. Korber Pharma Software's proven track record in supporting pharmaceutical, biotechnology, and cell and gene therapy manufacturers informed the sole-source selection. No small business set-aside was used for this acquisition, and the contract includes a base year period with four option years, allowing the NIH Clinical Center to leverage an integrated solution designed to meet the unique regulatory and operational demands of advanced cellular therapy production.
Quick answers
Who was awarded contract 75N90024C00029?
75N90024C00029 was awarded to Korber Pharma Software, Inc. by NIH Clinical Center (National Institutes of Health) on August 1, 2024.
How much is contract 75N90024C00029 worth?
The government has obligated $955,560 on 75N90024C00029.
Was contract 75N90024C00029 competed?
The extent of competition for 75N90024C00029 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award